References
- Flynn A.M., Kelly J. “Evaluation of fetal well-being by antepartum fetal heart monitoring”. Br. Med. J. 1977; 1: 936
- Hon E.H. An Atlas of fetal heart rate patterns. Harty Press, New Haven 1968
- Högstedt S., Lindeberg S., Axelsson O., Lindberg B.S., Lindmark G., Rane A., Sandström B. A prospective controlled trial of metoprolol - hydralazine treatment in hypertension during pregnancy. Acta Obstet. Gynecol. Scand., in press
- Karlberg P., Engström L. Swedish growth charts 1979
- Lindberg B.S., Sandström B. How Swedish obstetricians manage hypertension in pregnancy. Acta Obstet. Gynecol. Scand. 1981; 60: 327
- Long A.M., Abell D.A., Beischer N.A. “Fetal growth retardation and preeclampsia”. Br. J. Obstet. Gyn. 1980; 87: 13
- Lundborg P., Agren G., Lindeberg S., Sandström B. “Disposition of metoprolol in the newborn”. Br. J. Clin. Pharmac. 1981; 12: 599
- Martin C.B. “Regulation of the fetal heart rate and genesis of FHR patterns”. Semin. Perinatol. 1878; 2: 131
- Mirkin B. Perinatal Pharmacology and Therapeutics. Academic Press, New York, San Francisco, London 1976
- Montan S., Solum T., Sjöberg N.O. “Influence of the β - adrenoceptor blocker atenolol on antenatal cardiotocography”. Acta Obstet. Gynecol. Scand., suppl. 1984; 118: 99
- Page E.W., Christianson R. “Influence of blood pressure changes with and without proteinuria of pregnancy. Am. J. Obstet. Gynecol. 1976; 126: 821
- Rubin P.C. “Betablockers in pregnancy”. New Eng. J. of Medicine 1981; 305: 1323
- Solum T., Ingemarsson I. “Selection criteria for antenatal cardiotocography”. Z. Geburtsh. u. Perinat. 1979; 183: 212
- Thorley K.J., Mc Ainsh J., Cruickshank J.K. “Atenolol in the treatment of pregnancy induced hypertension”. Br. J. Clin. Pharmac. 1981; 12: 725
- Vink G.J., Moodley J., Philpott R.H. “Effect of dihydralazine on the fetus in the treatment of maternal hypertension”. Obstet. Gynecol. 1980; 55: 519